Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus

被引:34
|
作者
McCance, D. R. [1 ]
Damm, P. [2 ]
Mathiesen, E. R. [3 ]
Hod, M. [4 ]
Kaaja, R. [5 ]
Dunne, F.
Jensen, L. E. [6 ]
Mersebach, H. [6 ]
机构
[1] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland
[2] Univ Copenhagen Hosp, Dept Obstet, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark
[4] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Helen Schneider Hosp Women,Perinatal Div, IL-49100 Petah Tiqwa, Israel
[5] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[6] Novo Nordisk, Global Dev, Bagsvaerd, Denmark
关键词
human insulin; insulin antibody; insulin aspart; pregnancy; type; 1; diabetes;
D O I
10.1007/s00125-008-1120-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2141 / 2143
页数:3
相关论文
共 50 条
  • [41] A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
    Heise, Tim
    Hoevelmann, Ulrike
    Zijlstra, Eric
    Stender-Petersen, Kirstine
    Jacobsen, Jacob Bonde
    Haahr, Hanne
    DRUGS & AGING, 2017, 34 (01) : 29 - 38
  • [42] A direst comparison of insulin aspart and insulin lispro in patients with type 1 diabetes
    Plank, J
    Wutte, A
    Brunner, G
    Siebenhofer, A
    Semlitsch, B
    Sommer, R
    Hirschberger, S
    Pieber, TR
    DIABETES CARE, 2002, 25 (11) : 2053 - 2057
  • [43] Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus
    Pettitt, DJ
    Kolaczynski, JW
    Ospina, P
    Jovanovic, L
    DIABETES CARE, 2003, 26 (01) : 183 - 186
  • [44] Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus
    Atkin, Stephen
    Javed, Zeeshan
    Fulcher, Gregory
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (06) : 375 - 388
  • [45] A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus
    Rostami, Parastoo
    Setoodeh, Aria
    Rabbani, Ali
    Nakhaei-Moghadam, Maryam
    Najmi-Varzaneh, Farnaz
    Rezaei, Nima
    IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) : 173 - 178
  • [46] Insulin Degludec and Insulin Degludec/Insulin Aspart: A Review of Their Use in the Management of Diabetes Mellitus
    Gillian M. Keating
    Drugs, 2013, 73 : 575 - 593
  • [47] Insulin Degludec and Insulin Degludec/Insulin Aspart: A Review of Their Use in the Management of Diabetes Mellitus
    Keating, Gillian M.
    DRUGS, 2013, 73 (06) : 575 - 593
  • [48] A Pregnant Patient with Brittle Type 1 Diabetes Successfully Managed by CSII Therapy with Insulin Aspart
    Higuchi, Chigusa
    Tone, Atsuhito
    Iseda, Izumi
    Tsukamoto, Keiko
    Katayama, Akihiro
    Wada, Jun
    Shikata, Kenichi
    Hida, Kazuyuki
    JOURNAL OF DIABETES & METABOLISM, 2010, 1 (01)
  • [49] Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus
    Mantaj, Urszula
    Gutaj, Pawel
    Ozegowska, Katarzyna
    Zawiejska, Agnieszka
    Wroblewska-Seniuk, Katarzyna
    Olejniczak, Danuta
    Wender-Ozegowska, Ewa
    GINEKOLOGIA POLSKA, 2019, 90 (03) : 154 - 160
  • [50] Advantages of sensor-augmented insulin pump therapy for pregnant women with type?1 diabetes mellitus
    Imafuku, Hitomi
    Tanimura, Kenji
    Masuko, Naohisa
    Tomimoto, Masako
    Shi, Yutoku
    Uchida, Akiko
    Deguchi, Masashi
    Fujioka, Kazumichi
    Yamamoto, Akane
    Yoshino, Kei
    Hirota, Yushi
    Ogawa, Wataru
    Terai, Yoshito
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (12) : 1383 - 1390